Top compounds associated with response to KLRC4


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BRD-K30019337 CTRPv2 pan-cancer AAC 0.02 0.8
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.0099 0.8
mRNA CIL55 CTRPv2 pan-cancer AAC -0.016 0.8
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA PF-3758309 CTRPv2 pan-cancer AAC -0.012 0.8
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.0096 0.8
mRNA VU0155056 CTRPv2 pan-cancer AAC -0.0097 0.8
Download CSV